Treatment of Herpes Simplex Keratitis in HSV Endothelial Keratitis
Clinical Scenario
This protocol addresses herpes simplex keratitis presenting specifically as HSV endothelial keratitis — a form of keratitis involving the endothelial layer of the cornea driven by HSV infection. The clinical context and combination approach required in this setting differ from other forms of HSV keratitis.
Condition
HSV endothelial keratitis is a distinct clinical entity within the spectrum of herpes simplex keratitis. Its management requires a specific combination strategy, and the evidence base guiding treatment in this sub-population is well established in clinical guidelines.
Treatment Approach (Partial Overview)
The preferred treatment involves a topical corticosteroid agent used in conjunction with an oral antiviral agent. The specific agents selected, their dosing schedules, and the full clinical algorithm are outlined in the complete protocol.
Full regimen details — including agent selection, dose, frequency, and duration — are available via the structured protocol below.
References
- A topical corticosteroid agent in conjunction with an oral antiviral agent is the preferred treatment for HSV endothelial keratitis.
- An additional open label study of 43 patients with HSV endothelial keratitis compared topical acyclovir ointment 3% five times daily to oral acyclovir 400 mg five times daily in patients also treated with topical prednisolone 0.05%.
View source ↗